Immediate Impact
71 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Multifunctional nanoparticle-mediated combining therapy for human diseases
2024 Standout
Works of Flavia Impronta being referenced
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
2019
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Flavia Impronta | 133 | 211 | 134 | 9 | 308 | |
| Kiyofumi Honda | 111 | 193 | 176 | 10 | 320 | |
| Chay Ngee Lim | 165 | 213 | 125 | 11 | 311 | |
| Craig Laughton | 77 | 110 | 127 | 8 | 354 | |
| Aowen Zhuang | 98 | 147 | 110 | 18 | 364 | |
| Lynetta J. Jobe | 95 | 130 | 124 | 7 | 343 | |
| Samantha Ho | 129 | 192 | 145 | 5 | 277 | |
| Nils Ekström | 56 | 265 | 170 | 11 | 359 | |
| Domenica A. McCarthy | 82 | 129 | 87 | 15 | 290 | |
| Evangelia Tzeravini | 81 | 181 | 91 | 12 | 281 | |
| Wenying Huang | 78 | 219 | 165 | 9 | 351 |
All Works
Loading papers...